<HTML>
<HEAD>
   <TITLE>inn8k20090205.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing</TITLE>
</HEAD>

<BODY bgcolor="#ffffff">



<A name="page_1"></A>

<P align="center">
<FONT size=4 face="serif">UNITED STATES</FONT><BR>
<FONT size=4 face="serif">SECURITIES AND EXCHANGE COMMISSION</FONT><BR>
<FONT size=4 face="serif">WASHINGTON, DC 20549</FONT></P>
<P align="center">
<B><FONT size=5 face="serif">FORM 8-K</FONT></B><BR>
<B><FONT size=2 face="serif">CURRENT REPORT</FONT></B></P>
<P align="center">
<B><FONT size=2 face="serif">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</FONT></B></P>
<P align="center">
<FONT size=2 face="serif">Date of report (Date of earliest event reported: January 30, 2009)</FONT></P>
<P align="center">
<B><FONT size=5 face="serif">Innophos, Inc.</FONT></B><BR>
<B><FONT size=5 face="serif">Innophos Holdings, Inc.</FONT></B><BR>
<FONT size=1 face="serif">(Exact name of Registrants as specified in their Charters)</FONT></P>
<TABLE border=0 align="center" cellspacing=0 cellpadding=0>
<TR>
     <TD width=37%></TD>
     <TD width=30%></TD>
     <TD width=31%></TD></TR>
<TR valign="bottom">
	<TD align=center nowrap>
<B><FONT size=2 face="serif">Delaware</FONT></B>&nbsp;
	</TD>
	<TD align=center nowrap>
<B><FONT size=2 face="serif">333-129951</FONT></B>&nbsp;
	</TD>
	<TD align=center nowrap>
<B><FONT size=2 face="serif">20-1380712</FONT></B>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center nowrap>
<B><FONT size=2 face="serif">Delaware</FONT></B>&nbsp;
	</TD>
	<TD align=center nowrap>
<B><FONT size=2 face="serif">001-33124</FONT></B>&nbsp;
	</TD>
	<TD align=center nowrap>
<B><FONT size=2 face="serif">20-1380758</FONT></B>&nbsp;
	</TD>
</TR>
<TR valign="bottom">
	<TD align=center nowrap>
<FONT size=1 face="serif">(States or other jurisdictions of incorporation)</FONT>&nbsp;
	</TD>
	<TD align=center nowrap>
<FONT size=1 face="serif">(Commission File Numbers)</FONT>&nbsp;
	</TD>
	<TD align=center nowrap>
<FONT size=1 face="serif">(IRS Employer Identification Nos.)</FONT>&nbsp;
	</TD>
</TR>
</TABLE><BR>
<P align="center">
<B><FONT size=2 face="serif">259 Prospect Plains Road</FONT></B><BR>
<B><FONT size=2 face="serif">Cranbury, New Jersey 08512</FONT></B></P>
<P align="center">
<FONT size=1 face="serif">(Address of Principal Executive Offices, including Zip Code)</FONT></P>
<P align="center">
<B><FONT size=2 face="serif">(609) 495-2495</FONT></B></P>
<P align="center">
<FONT size=1 face="serif">(Registrants&#146; Telephone Number, Including Area Code)</FONT></P>
<P align="center">
<B><FONT size=2 face="serif">Not Applicable</FONT></B></P>
<P align="center">
<FONT size=1 face="serif">(Former names or former addresses, if changed since last report)</FONT></P>
<P align="left">
<FONT size=2 face="serif">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of</FONT><BR>
<FONT size=2 face="serif">the registrant under any of the following provisions:</FONT><BR>
<FONT size=2 face="serif">[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT><BR>
<FONT size=2 face="serif">[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)</FONT><BR>
<FONT size=2 face="serif">[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))</FONT><BR>
<FONT size=2 face="serif">[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))</FONT></P>

<HR noshade align="center" width="100%" size=2 style="page-break-after:always;">



<A name="page_2"></A>
<P align=left><B><FONT face=serif size=2>Item 1.01 Entry into a Material Definitive Agreement.</FONT></B><BR>
<BR>
<FONT face=serif size=2>Registrant Innophos, Inc. entered into a Binding Memorandum of Agreement, or MOA, dated as of January 30, 2009, with</FONT><BR>
<FONT face=serif size=2>Colgate Palmolive Company, or Colgate, which, among other things, provides for extension of the term of (i) a Supply</FONT><BR>
<FONT face=serif size=2>Agreement, dated as of June 18, 1998, by and among Colgate , Inmobiliaria Hills, S.A. de C.V. and Rhone-Poulenc de</FONT><BR>
<FONT face=serif size=2>Mexico, S.A. de C.V., or RP-Mexico, (which agreement was assigned from R-P Mexico to Registrant and its affiliates in</FONT><BR>
<FONT face=serif size=2>connection with its acquisition of its business as of August 13, 2004) and (ii) an Operations Agreement, dated as of June</FONT><BR>
<FONT face=serif size=2>18, 1998, by and among Mission Hills, S.A. de C.V., Inmobiliaria Hills, S.A. de C.V. and RP-Mexico, and the attached</FONT><BR>
<FONT face=serif size=2>real estate lease (which agreement was similarly assigned to Registrant and its affiliates). The two noted agreements were</FONT><BR>
<FONT face=serif size=2>filed previously by Registrant Innophos, Inc., most recently as Exhibits 10.9 and 10.10, respectively, to its Annual Report</FONT><BR>
<FONT face=serif size=2>on Form 10-K for the fiscal year ended December 31, 2007. Under the MOA, the terms of these agreements have been set</FONT><BR>
<FONT face=serif size=2>to expire on May 31, 2013 and will automatically renew through May 31, 2016 unless canceled by either party in writing</FONT><BR>
<FONT face=serif size=2>no later than May 31, 2012, and will again automatically renew through May 31, 2018 unless canceled by either party in</FONT><BR>
<FONT face=serif size=2>writing no later than May 31, 2015. The MOA also provides for newly negotiated volumes, prices, terms of sale and other</FONT><BR>
<FONT face=serif size=2>conditions according to which the Registrant&#146;s affiliates are to operate the Mission Hills plant and to produce and sell a</FONT><BR>
<FONT face=serif size=2>range of Di-Calcium Phosphate products to Colgate and its affiliates under definitive agreements contemplated by the</FONT><BR>
<FONT face=serif size=2>MOA to be entered into among the parties.</FONT><BR>
<BR>
<FONT face=serif size=2>A copy of the MOA (in redacted form subject to a confidential treatment request filed with the Securities and Exchange</FONT><BR>
<FONT face=serif size=2>Commission) is filed as Exhibit 99.1 to this Current Report on Form 8-K.</FONT><BR>
<BR>
<B><FONT face=serif size=2>Item 8.01 Other Items.</FONT></B><BR>
<BR>
<FONT face=serif size=2>Registrant Innophos, Inc.&nbsp;previously reported obtaining favorable appellate rulings in the New York state courts confirming full</FONT><BR>
<FONT face=serif size=2>indemnity from affiliates of Rhodia S.A., or Rhodia, for water charges sought to be imposed by the Mexican National</FONT><BR>
<FONT face=serif size=2>Waters Commission, or CNA, on Innophos&#146;s Coatzacoalcos, Veracruz, Mexico facility for periods prior to the August 13,</FONT><BR>
<FONT face=serif size=2>2004 acquisition date of that facility from Rhodia. The CNA claims currently pending (totaling approximately $23</FONT><BR>
<FONT face=serif size=2>million at current exchange rates) cover the period 1998-2002 and are being defended in Mexican appeals courts.</FONT><BR>
<FONT face=serif size=2>Following the New York appellate rulings, the Registrant returned to the New York trial court to pursue remaining</FONT><BR>
<FONT face=serif size=2>claims, including indemnity for related losses and damages for breaches of covenants, representations and warranties,</FONT><BR>
<FONT face=serif size=2>including liability for increased water charges incurred following the acquisition. These contingent liabilities, if imposed</FONT><BR>
<FONT face=serif size=2>by CNA on the same basis as the pending claims by that agency, would total approximately $9 million at current exchange</FONT><BR>
<FONT face=serif size=2>rates. Rhodia filed a motion for partial summary judgment asserting that those claims were precluded under the</FONT><BR>
<FONT face=serif size=2>acquisition agreement. On February 3, 2009, the trial court judge denied Rhodia&#146;s motion, allowing the Registrant's case</FONT><BR>
<FONT face=serif size=2>to continue. There has been no schedule established for discovery or trial of at this time.</FONT></P>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" noShade SIZE=2>


<A name="page_3"></A>
<P align=left><B><U><FONT face=serif size=2>Item 9.01 Financial Statements and Exhibits.</FONT></U></B></P>
<P align=left><B><U><FONT face=serif size=2>(d) Exhibit No.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Description</FONT></U></B><BR>
<BR>
<FONT face=serif size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Form of Memorandum of Agreement dated January 30, 2009</FONT></P>
<P align=left><FONT size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <B><FONT face=serif>SIGNATURES</FONT></B></FONT></P>
<P align=left><FONT face=serif size=2>According to the requirements of the Securities Exchange Act of 1934, the Registrants have duly caused this report to be</FONT><BR>
<FONT face=serif size=2>signed on their behalf by the undersigned, hereunto duly authorized.</FONT></P>
<P align=left><FONT size=2></FONT>&nbsp;</P>
<P align=left><FONT size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><B><FONT face=serif size=2>INNOPHOS HOLDINGS, INC.</FONT></B></P>
<TABLE cellSpacing=0 cellPadding=0 border=0>
<TR>
     <TD width="52%"></TD>
     <TD width="6%"></TD>
     <TD width="40%"></TD></TR>
<TR vAlign=bottom>
     <TD noWrap align=left>&nbsp; </TD>
     <TD noWrap align=left><FONT face=serif size=2>By:</FONT>&nbsp; </TD>
     <TD noWrap align=left><U><FONT face=serif size=2>/s/ William Farran</FONT></U>&nbsp; </TD></TR>
<TR vAlign=bottom>
     <TD noWrap align=left>&nbsp; </TD>
     <TD noWrap align=left><FONT face=serif size=2>Name:</FONT>&nbsp; </TD>
     <TD noWrap align=left><FONT face=serif size=2>William Farran</FONT>&nbsp; </TD></TR>
<TR vAlign=bottom>
     <TD noWrap align=left>&nbsp; </TD>
     <TD noWrap align=left><FONT face=serif size=2>Title:</FONT>&nbsp; </TD>
     <TD noWrap align=left><FONT face=serif size=2>Vice President, General Counsel &amp; Secretary</FONT>&nbsp; </TD></TR></TABLE><BR>
<P align=left><FONT face=serif size=2>Dated: February 5, 2009</FONT></P>
<HR style="PAGE-BREAK-AFTER: always" align=center width="100%" noShade SIZE=2>

</BODY>

</HTML>
[{"type": "8-K", "sequence": "1", "filename": "inn8k20090205.htm", "secsgml_size_bytes": 11710}]
{"company-data": {"conformed-name": "Innophos Holdings, Inc.", "cik": "0001364099", "assigned-sic": "5160", "irs-number": "201380758", "fiscal-year-end": "1207"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-33124", "film-number": "09573471"}, "business-address": {"street1": "259 PROSPECT PLAINS ROAD", "city": "CRANBURY", "state": "NJ", "zip": "08512", "phone": "(609) 495 2495"}, "mail-address": {"street1": "259 PROSPECT PLAINS ROAD", "city": "CRANBURY", "state": "NJ", "zip": "08512"}}
inn8k20090205.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported: January 30, 2009)
Innophos, Inc.
Innophos Holdings, Inc.
(Exact name of Registrants as specified in their Charters)
Delaware
333-129951
20-1380712
Delaware
001-33124
20-1380758
(States or other jurisdictions of incorporation)
(Commission File Numbers)
(IRS Employer Identification Nos.)
259 Prospect Plains Road
Cranbury, New Jersey 08512
(Address of Principal Executive Offices, including Zip Code)
(609) 495-2495
(Registrants' Telephone Number, Including Area Code)
Not Applicable
(Former names or former addresses, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 1.01 Entry into a Material Definitive Agreement.
Registrant Innophos, Inc. entered into a Binding Memorandum of Agreement, or MOA, dated as of January 30, 2009, with
Colgate Palmolive Company, or Colgate, which, among other things, provides for extension of the term of (i) a Supply
Agreement, dated as of June 18, 1998, by and among Colgate , Inmobiliaria Hills, S.A. de C.V. and Rhone-Poulenc de
Mexico, S.A. de C.V., or RP-Mexico, (which agreement was assigned from R-P Mexico to Registrant and its affiliates in
connection with its acquisition of its business as of August 13, 2004) and (ii) an Operations Agreement, dated as of June
18, 1998, by and among Mission Hills, S.A. de C.V., Inmobiliaria Hills, S.A. de C.V. and RP-Mexico, and the attached
real estate lease (which agreement was similarly assigned to Registrant and its affiliates). The two noted agreements were
filed previously by Registrant Innophos, Inc., most recently as Exhibits 10.9 and 10.10, respectively, to its Annual Report
on Form 10-K for the fiscal year ended December 31, 2007. Under the MOA, the terms of these agreements have been set
to expire on May 31, 2013 and will automatically renew through May 31, 2016 unless canceled by either party in writing
no later than May 31, 2012, and will again automatically renew through May 31, 2018 unless canceled by either party in
writing no later than May 31, 2015. The MOA also provides for newly negotiated volumes, prices, terms of sale and other
conditions according to which the Registrant's affiliates are to operate the Mission Hills plant and to produce and sell a
range of Di-Calcium Phosphate products to Colgate and its affiliates under definitive agreements contemplated by the
MOA to be entered into among the parties.
A copy of the MOA (in redacted form subject to a confidential treatment request filed with the Securities and Exchange
Commission) is filed as Exhibit 99.1 to this Current Report on Form 8-K.
Item 8.01 Other Items.
Registrant Innophos, Inc. previously reported obtaining favorable appellate rulings in the New York state courts confirming full
indemnity from affiliates of Rhodia S.A., or Rhodia, for water charges sought to be imposed by the Mexican National
Waters Commission, or CNA, on Innophos's Coatzacoalcos, Veracruz, Mexico facility for periods prior to the August 13,
2004 acquisition date of that facility from Rhodia. The CNA claims currently pending (totaling approximately $23
million at current exchange rates) cover the period 1998-2002 and are being defended in Mexican appeals courts.
Following the New York appellate rulings, the Registrant returned to the New York trial court to pursue remaining
claims, including indemnity for related losses and damages for breaches of covenants, representations and warranties,
including liability for increased water charges incurred following the acquisition. These contingent liabilities, if imposed
by CNA on the same basis as the pending claims by that agency, would total approximately $9 million at current exchange
rates. Rhodia filed a motion for partial summary judgment asserting that those claims were precluded under the
acquisition agreement. On February 3, 2009, the trial court judge denied Rhodia's motion, allowing the Registrant's case
to continue. There has been no schedule established for discovery or trial of at this time.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibit No.       Description
99.1                    Form of Memorandum of Agreement dated January 30, 2009
SIGNATURES
According to the requirements of the Securities Exchange Act of 1934, the Registrants have duly caused this report to be
signed on their behalf by the undersigned, hereunto duly authorized.
INNOPHOS HOLDINGS, INC.
By:
/s/ William Farran
Name:
William Farran
Title:
Vice President, General Counsel & Secretary
Dated: February 5, 2009